The Moslehi laboratory is recruiting a post-doctoral fellow with a PhD in immunology or molecular biology. See below! https://t.co/frfCFvfz5o Below information about the lab: https://t.co/xN3qDdqMvA Interested candidates can email me with CV! javid.moslehi@ucsf.edu

We’re pleased to share our review in @CellRepMed on #iPSC & #tissueengineering for #cardiometabolic disease & #cardiooncology by Ana Kojić, Javid Moslehi & Bonnie Ky. @StanfordCVI, @CardioOncology @StanfordDeptMed Honored it was featured as journal cover: https://t.co/eZBTgVloRT

Introducing Goodfin Futures, a fireside chat series where we bring the sharpest minds to talk about where wealth gets built next! For the first one, we have @Scobleizer talking about AI's next inflection point. 20+ years tracking platform shifts. Thousands of founder

Optimizing Cardiac Outcomes: Anne Blaes, Eric Yang, and Javid Moslehi will address this topic in an educational session at #SABCS25 (December 9-12). Learn more: https://t.co/ux6HtN0k6u @BlaesAnneMD @datsunian @CardioOncology

Congratulations to Dr. Akito Shindo @shinakito for being a finalist for the young investigator award at #ESCCongress2025! @shinakito will be joining us at @UCSFCardiology as #CardioOnc Fellow in 2026! https://t.co/SiYZV5EhyH

Dr. Javid Moslehi @CardioOncology @UCSFMedicine presents on myocarditis, sharing case studies and highlighting the severity of this adverse event #IOSymposium2025 @ANCO_News @MOASC_Office

Performance Matters. Precision Matters. Predictability Matters. Introducing OptiBLOCK mini

🧬 New insights from iPSC models reveal how heart disease and cancer share genetic and metabolic pathways. A promising step toward personalized therapies in cardio-oncology. #CardioOnc #iPSCs @StanfordCVI @CardioOncology 📰 https://t.co/I0Y9jT6tAc

New JAK inhibitor drugs successfully treated a patient w/ acute myocarditis, UCSF researchers report in @CircAHA. “The team is hopeful that these early results can lead to an eventual (clinical) trial for patients,” Dr. Javid Moslehi @CardioOncology says.

The Moslehi Lab is now 10 years old! A few pics from the summer! Welcoming new members to the lab! We are still recruiting! Send me an email with your CV! @UCSFCardiology @UCSFCancer https://t.co/t6cbn98z1w

Talk about an absolute giant! Few people have contributed as much to @UCSF as the great William Rutter. Arguably the most important recruit by the great Holly Smith! Transformed basic science at UCSF! @UCSF_RDO @RutterLab https://t.co/vi5kngQc0k https://t.co/v1KdOUwISL

Embarrassed not to tag @JohnPowerMD on original tweet! Came to @DrJESalem & I as Vandy intern 2 work on this project (2018!) & has been leading this from day 1! Then @UCSDCardFellows @UCSDCardiology & now w/ @DLBHATTMD @MountSinaiHeart @IcahnMountSinai @MSMCardsFellows #EPeeps

Lots of new data to go through but here is one critical 1: we still have a long way to go in terms of treatment for patients. Despite some early (& flawed) data, corticosteroids do nothing (even at high doses) for patients...

We additionally develop a risk score using these criteria which we hope helps clinicians across the globe!

Q3 Earnings Strategy: Trading Semiconductors, Biotechs, and the Magnificent 7 with @DirexionLETFs *Sponsored

Here are the key risk factors: Presence of thymoma, Time of initial exposure to therapy, muscular symptoms, ECG criteria, LV dysfunction & degree of troponin elevation! Confirmed in a validation cohort through @MassGenBrigham (special thanks to @ItzhakiOsnat & Anju Nohria!)

Over the last 9 years, we have collected clinical cases from around the globe! 17 countries, 127 institutions and 757 cases! We determine the primary drivers of bad outcome in patient (i.e. what clinical factors determine death when a patient presents with ICI-myocarditis?)

Our group has been interested in understanding the clinical features of ICI-myocarditis ever since we described the first 2 patients with ICI-myocarditis in @NEJM in 2016 along with #DougJohnson @BalkoLab & others!

Excited to report this important collaboration which we hope helps us understand ICI-myocarditis better, published in #EHJ today! Along with the great @DrJESalem! @ehj_ed @JBauersachsMD #CardioOnc @UCSFCardiology @UCSFCancer https://t.co/3jsZaZ2SuQ

The future of science is open — and we’re building it together. Introducing Open Science, our new X community where researchers, founders & curious minds collide to explore DeSci, biotech & innovation. Join us ⬇️

Excited to share this video of the @UCSFCardiology research and clinical efforts in cardio-oncology & cardio-immunology! #CardioOnc @myocarditisfndn @ICOSociety @AHA_Research @kiniksa @American_Heart @NatureCVR @UCSFHospitals https://t.co/n38PkD0AFC

Great spotlight on @AmirZMunir! Dr. Munir completed #CardioOnc fellowship at @UCSFCardiology & just joined our faculty. He has been identifying novel mediators of myocarditis including chemokine receptors! @SarnoffCardio @UCSFCancer https://t.co/thyQMx9Ir8

The Moslehi Lab will host the CVRI "Liver Rounds" (e.g., Happy Hour) tomorrow for CVRI retreat! Hope to see all colleagues interested in #CVResearch from CVRI & beyond there! @m_alexanian @benoitbruneau @UCSFCardiology @GuonHuang @NicolasAvilaJA @ZaroLab @ReiterLab See you there!

Finally, we are recruiting fellows for 2026 at UCSF for #CardioOnc & Immunology! Also looking for those w/ basic and translational interest (&background)! Who wants to join this distinguished group of fellows & alumni? Email me if interested: javid.moslehi@ucsf.edu

This is what learning your lesson in Trading looks like Drop a like if you're ready to get gains like this! ❤️ Link in Bio!

Lots of collaborators for this study & our unique registry now w/ > 1300 cases! @PalaskasN @anita_deswal @LorenzLehmann @CautelaJennifer @salimhayek @HanZhuMD @Richardkcheng2 @CardioOncoCaen @CardioOnc_MR_CT @LauferPerl @AartiAsnaniMD @MandarArasMD & many others!